Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

NCT00141011 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

277

Enrollment

INDUSTRY

Sponsor class

Stopped Futility

Conditions

Stroke
Cerebral Ischemia
Brain Infarction

Interventions

DRUG: Ancrod (Viprinex)
DRUG: Placebo

Sponsor

Neurobiological Technologies